$725 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 110 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | ALLERGAN PLC | $10,003,000 | -0.9% | 60,000 | 0.0% | 1.38% | -10.0% | |
| INNT | INNOVATE BIOPHARMACEUTICLS I | $7,844,000 | -36.0% | 980,502 | 0.0% | 1.08% | -41.9% | |
| V | VISA INC | $5,351,000 | +10.7% | 40,401 | 0.0% | 0.74% | +0.5% | |
| ORLY | O REILLY AUTOMOTIVE INC NEW | $2,967,000 | +10.6% | 10,844 | 0.0% | 0.41% | +0.5% | |
| TEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0 | $970,000 | +38.0% | 2,135 | 0.0% | 0.13% | +25.2% | ||
| AAP | ADVANCE AUTO PARTS INC | $724,000 | +14.4% | 5,336 | 0.0% | 0.10% | +4.2% | |
| SERV | SERVICEMASTER GLOBAL HLDGS I | $565,000 | +17.0% | 9,500 | 0.0% | 0.08% | +6.8% | |
| UNH | UNITEDHEALTH GROUP INC | $491,000 | +14.7% | 2,000 | 0.0% | 0.07% | +4.6% | |
| SITE | SITEONE LANDSCAPE SUPPLY INC | $252,000 | +9.1% | 3,000 | 0.0% | 0.04% | 0.0% | |
| MHK | MOHAWK INDS INC | $236,000 | -7.5% | 1,100 | 0.0% | 0.03% | -15.4% | |
| SNA | SNAP ON INC | $220,000 | +8.9% | 1,366 | 0.0% | 0.03% | -3.2% | |
| ULTI | ULTIMATE SOFTWARE GROUP INC | $206,000 | +5.6% | 800 | 0.0% | 0.03% | -6.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.